LAUREN HADNEY: Open Payments
NPI 1124525449 · PARMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 30 payments from 5 companies in 2025. Trend: 2023 $1,857 · 2024 $609 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $273 |
| Novo Nordisk Inc | 5 | $76 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: QULIPTA, UBRELVY, ELIQUIS, Ozempic, Veozah, SHINGRIX, Wegovy, VRAYLAR.
Industry payments across OH — which companies pay providers there.
